Translational research community debates on the EGA and its impact on health
Credit: Peter Artymiuk, Wellcome Trust Images Barcelona, April 13, 2018 - Àngel Font; corporate director for the area of research and strategy of the "la...
NEWS INDEX
Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
13 April 2018, Paris, France: The final results of the palliative cohort of the SORAMIC study in patients with unresectable, locally advanced primary liver cancer...
‘Tic-tac-toe’-themed MRI technology easy win for neurological disease researchers
Credit: University of Pittsburgh Radiofrequency Research Facility PITTSBURGH (April 12, 2018) ... The University of Pittsburgh houses a whole-body 7 Tesla magnetic resonance imager (7T...
Scientists find positive workplace experiences among Americans with disabilities
Credit: Kessler Foundation A multidisciplinary team of researchers at Kessler Foundation and the University of New Hampshire, Institute on Disability (UNH-IOD), have authored a new...
US study reports dramatic reduction in likelihood of liver transplantation in patients with hepatoce
13 April 2018, Paris, France: Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive...
Long-term obeticholic acid treatment leads to reversal or stabilization of fibrosis/cirrhosis in patients with PBC
13 April 2018, Paris, France: The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid (OCA) leads to...
Alzheimer plaque affects different brain cells differently
(Linköping University) Amyloid beta, a protein linked with Alzheimer's disease, has different properties in different cell types in the brains of fruit flies. This is...
Two MDC scientists receive ERC grants worth several million euros
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) Basic researchers Gary Lewin and Norbert Hübner are investigating the molecular mechanisms underlying neurological and...
ESC Congress 2018 scientific program online
Sophia Antipolis, APRIL 13, 2018 The scientific programme of ESC Congress 2018 is online now. The world's largest cardiovascular congress will be held 25 to...
Automated analysis of biopsy samples enables rapid and reproducible quantification of NASH disease activity
13 April 2018, Paris, France: Deep-learning approaches to pattern recognition in liver biopsy samples have moved one step closer to clinical application, with a new...
Blocking matrix-forming protein might prevent heart failure
Credit: Cincinnati Children's CINCINNATI - Scientists used an experimental targeted molecular therapy to block a matrix-forming protein in heart cells damaged by heart attack, reducing...
Germany: compensated cirrhosis substantially increases comorbidities and healthcare costs for patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
13 April 2018, Paris, France: An analysis of outcomes and costs for German patients with non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) who develop compensated...
Measuring the risks of extreme temperatures on public health
Credit: Yang Liu, Brenda O. Hoppe, Matteo Convertino Heat and cold waves affect people with certain health conditions differently, highlighting the need for tailored public...
Phase 2 studies of two novel treatments for primary biliary cholangitis report encouraging results
ILC 2018: Ongoing Phase 2 studies of tropifexor and seladelpar report promising preliminary efficacy, safety and tolerability results, paving the way for longer-term studies in...
NGM282 — an engineered analogue of FGF19 — shows promise in patients with primary sclerosing cholangitis
13 April 2018, Paris, France: The fibroblast growth factor 19 (FGF19) engineered analogue, NGM282, inhibits bile acid synthesis, decreases markers of hepatic inflammation, and significantly...
POPULAR NEWS
-
Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges
-
New Drug Formulation Transforms Intravenous Treatments into Rapid Injections
-
Physicists Develop Visible Time Crystal for the First Time
-
Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases